Nomura Holdings Inc Alkermes Plc. Transaction History

Nomura Holdings Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $1.33 Million - $1.57 Million	49,000 New	49,000 $1.37 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $2.99 Million - $3.57 Million	136,149 New	136,149 $3.56 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $33.2 Million - $44.5 Million	-1,767,573 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $10.6 Million - $13.5 Million	-584,000 Reduced 24.83%	1,767,573 $33.1 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $1.22 Million - $1.75 Million	79,408 Added 3.49%	2,351,573 $47.1 Million
Q3 2020 Nov 12, 2020	BUY	$16.16 - $20.66 $36.7 Million - $46.9 Million	2,272,165 New	2,272,165 $37.7 Million
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $1.4 Million - $2.23 Million	-50,071 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $1.93 Million - $2.31 Million	50,071 New	50,071 $2.15 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $158,751 - $201,023	-3,914 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$53.61 - $67.26 $209,829 - $263,255	3,914 New	3,914 $227,000

372

175M

140K

143K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.